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Abstract
The chromatin regulator Aiolos and the transcriptional coactivator OBF-1 have been implicated in regulating aspects of B
cell maturation and activation. Mice lacking either of these factors have a largely normal early B cell development. However,
when both factors are eliminated simultaneously a block is uncovered at the transition between pre-B and immature B cells,
indicating that these proteins exert a critical function in developing B lymphocytes. In mice deficient for Aiolos and OBF-1,
the numbers of immature B cells are reduced, small pre-BII cells are increased and a significant impairment in
immunoglobulin light chain DNA rearrangement is observed. We identified genes whose expression is deregulated in the
pre-B cell compartment of these mice. In particular, we found that components of the pre-BCR, such as the surrogate light
chain genes l5 and VpreB, fail to be efficiently silenced in double-mutant mice. Strikingly, developmentally regulated
nuclear repositioning of the l5 gene is impaired in pre-B cells lacking OBF-1 and Aiolos. These studies uncover a novel role
for OBF-1 and Aiolos in controlling the transcription and nuclear organization of genes involved in pre-BCR function.
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Introduction
The developmental fate of B lymphocytes is tightly controlled by
a large number of transcription factors [1–3]. The differential
expression of factors like PU.1, Ikaros, ID2, Notch-1, E2A, EBF
and PAX5 controls the progressive commitment of pluripotent
hematopoietic stem cells to the lymphoid and then to the B cell
lineage. These and other factors orchestrate the transcriptional
program required for proper developmental progression along the
B cell pathway. Rearrangement of the immunoglobulin heavy
chain (IgH: mHC) takes place at the pre-BI cell stage and its
functionality is checked at the subsequent pre-BII cell stage [4,5].
At this stage, the heavy chain associates with the surrogate light
chain (SLC), encoded by the VpreB and l5 genes, to form the pre-B
cell receptor (pre-BCR), which is displayed at the cell surface. This
represents a first checkpoint in early B cell development. Signaling
by the pre-BCR induces a proliferative burst and cell survival,
followed by downregulation of the VpreB and l5 genes, exit from
the cell cycle and induction of immunoglobulin light chain
rearrangement (IgL: k or l) in small pre-BII cells [6]. Surface
expression of a functional B cell receptor (BCR), consisting of IgH
paired with IgL, is essential for progression through the second
checkpoint. The immature B cells that pass this selection exit the
bone marrow and migrate to the spleen where they continue their
differentiation through several transitional B cell stages [7,8],
which undergo negative selection processes [9]. A small number of
the surviving cells, possibly having a lower level of BCR signaling
[10], differentiate into the naı ¨ve and sessile marginal zone B
(MZB) cells, while the majority of the surviving transitional B cells
become naı ¨ve follicular B cells. These long-lived cells circulate
through the follicles of the spleen, lymph nodes and the bone
marrow.
The transcriptional coactivator OBF-1 (Bob-1, Oca-B) is
essential in late B cell development. OBF-1 is predominantly
expressed in B lymphocytes and can form ternary complexes on
permissive octamer sites with the POU domain transcription
factors Oct1 and/or Oct2 [11–13]. Work from several laboratories
has shown that the deletion of OBF-1 leads to a reduction in the
newly arriving transitional B cells in the spleen and to diminished
numbers of recirculating B lymphocytes in the bone marrow
[14,15]. Furthermore, OBF-1 mutant mice have a severely
impaired T cell dependent (TD) humoral immune response and
fail to form germinal centers (GC) [16,17]. The absence of GCs
may at least in part be due to the reduced expression of the Ets
factor Spi-B in OBF-1
2/2 B cells [18]. In addition, the reduced
humoral immune response correlates with the requirement of
OBF-1 for formation of antibody secreting cells [19]. OBF-1 is also
required for a normal proliferative and signaling response to BCR
stimulation [20,21], and in a C57BL/6 genetic background, it is
also critical for the development of MZ B cells [22].
The zinc-finger transcription factor Aiolos is expressed in early
B and T cell subsets as well as in mature B cells [23]. It can form
heterodimers with Ikaros and it activates or represses genes by
recruiting chromatin remodeling complexes [24–26]. Ablation of
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of what is observed in OBF-1
2/2 mice: a slight increase in pre-B
cells in the bone marrow, reduction of peritoneal B1 B cells and
most notably constitutive formation of GCs [10,27]. Aiolos
deficient B cells show an enhanced proliferative and signaling
response to BCR stimulation, which may at least partly explain the
spontaneous formation of GCs and the development of autoan-
tibodies in Aiolos deficient mice [21,27]. In mice lacking Aiolos,
anti-DNA autoantibodies accumulate as immune complexes in the
kidney, which can result in signs of renal failure and symptoms
resembling those found in human systemic lupus erythematosus
(SLE) [21].
In contrast to the late developmental defects seen in the single-
mutants, the combined loss of Aiolos and OBF-1 has a strong
impact on early B cell development and results in a severe
reduction of the immature B cell pool in the bone marrow. The
effect on early B cell development is accompanied by a reduction
in the numbers of peripheral mature B cells and an absence of the
SLE-like symptoms [21]. The cellular and molecular mechanisms
underlying this phenotype are not well understood. Here we have
examined the synergistic role of Aiolos and OBF-1 within the
regulatory network that control early B cell development. For this,
pre-BII cells and their transcriptomes were characterized from
single-and double-mutant mice. RNA expression profiling re-
vealed that the genes encoding the SLC fail to be properly
downregulated in small pre-BII cells from Aiolos/OBF-1 double-
deficient mice. Moreover, three-dimensional DNA fluorescence in
situ hybridization (3D FISH) analysis demonstrated that the
subnuclear organization of the l5 locus and its correct relocaliza-
tion during B cell development strongly depend on Aiolos and
moderately on OBF-1.
Materials and Methods
Mice and cells
The Aiolos
2/2 and OBF-1
2/2 mice have been described
previously [16,27]. Animal experimentation was carried out
according to regulations effective in the Kanton of Basel-Stadt,
Switzerland as well as in accordance with the FMI internal
regulations under supervision of the FMI Animal Committee. The
mice were housed in groups of one to six animals at 25uC with a
12:12 h light-dark cycle. They were fed a standard laboratory diet
containing 0.8% phosphorus and 1.1% calcium (NAFAG 890,
Kliba, Basel, Switzerland). Food and water was provided ad libitum.
All mice were analyzed between 6 and 15 weeks of age. A20J is a
murine B cell lymphoma cell. Cells were cultured in RPMI 1640
supplemented with 10% fetal calf serum, 2 mM glutamine,
100 mg/ml penicillin, 100 mg/ml streptomycin, and 50 mM 2-
mercaptoethanol.
Antibodies and Flow Cytometry
Single cell suspensions of purified bone marrow cells or
splenocytes were stained with fluorochrome or biotin-labeled
antibodies. Cells were analyzed on a FACSCalibur (BD Im-
munocytometry Systems) using a lymphocyte live gate. Cell sorting
was carried out on a MoFLOW cell sorter (Dako-Cytomation).
Data were analyzed with CellQuest (BD Immunocytometry
Systems) and FlowJo (Tree Star) software. For intracellular
stainings, cells were fixed for 10 minutes with 2% paraformalde-
hyde/PBS and permeabilized with 0.1% saponin/PBS. At least
1610
6 cells were stained with the following antibodies: anti-B220-
APC (RA3-6B2); anti-CD25-Biotin or PE (7D4, BD Pharmingen),
anti-ckit PE (ACK4, BD Pharmingen), anti-IgM-FITC (1B4B1,
Southern Biotech); anti-IgD-Biotin (I-19); anti-pre-BCR-Biotin
(SL156); anti-l5-Biotin (LM34). For secondary stainings the
following strepdavidine conjugates were used: strepdavidine-
PECy7 (eBiosciences); streptavidine-PECy5.5 (Caltag).
Real time RT-PCR analysis
Bone marrow or splenic cells from 3,5 age-matched mice were
pooled and sorted. RNA was extracted from 4610
4 to 1610
6
primary cells or cell lines, using TRIzol or the AbsolutelyRNA
micro kit (Stratagene). The isolated total RNA was DNaseI-
digested to remove genomic contamination and first strand cDNA
was synthesized using oligo(dT) primers and Omniscript reverse
transcriptase (Qiagen). The real time PCR reactions were carried
out in an ABI Prism 7000 sequence detector (Applied Biosystems)
using the Gold 26SYBR green reaction mix (Eurogentec). Each
assay contained a duplicate and a minus RT control. The
efficiency for each real time PCR run was determined according to
[28]. The expression of the gene of interest was subsequently
normalized to the expression of the housekeeping genes RNA
Polymerase II or Ubiquitin C [29]. Normalization of expression data
was computed by the qGENE tool [30]. All real time PCR
amplicons were set across an exon-exon boundary. Primers used in
real time PCR reaction:
RPII F: TGCGCACCACGTCCAATGATA;
RPII R: AGGAGCGCCAAATGCCGATAA;
UBC F: AGGTCAAACAGGAAGACAGACGTA;
UBC R: TCACACCCAAGAACAAGCACA;
18s F: GCCCGAGCCGCCTGGATACC;
18s R: TCACCTCTAGCGGCGCAATACGAA;
l5 F: GAGACAACCCAACCCTCCAA;
l5 R: TGAGGCATCCACTGGTCAGA;
cy GSN F: CCGTCGCTGTCGCCGTCA;
cy GSN R: GCACCAGGTCAAACTTCTCCACAC;
Aio F: TCCTGGACAGATTAGCAAGCAA;
Aio R: GGGATTGTAGTTGCCATCGAA;
mOBF-1 F: CACGCCCAGTCACATTAAAGAA;
mOBF-1 R: TGTGGATTTTTGCCAGAGCAT;
RNA and RT-PCR
Total RNA was isolated from 1610
5 sorted cells and cDNA
synthesized as above. Immunoglobulin k cDNA was amplified
with 30 cycles at 62uC annealing temperature using the following
primers:
Vk deg F: GGCTGCAGSTTCAGTGGCAGTGGRTCWG
GRAC;
Ck R: GTCCTGATCAGTCCAACTGTTCAG;
Cell cycle analysis
Bone marrow pre-BI, large and small pre-BII and immature B
cells were isolated by cell sorting and fixed in 1% paraformalde-
hyde at 4uC overnight. After permeabilization with 70% ethanol
at 220uC the cells were stained with 50 mg/ml Propidium Iodide
(Sigma, P 4170) in PBS and treated with 0.1 mg/ml RNase A.
The cells were analyzed FACScalibur and the recorded data
analyzed with the ModFit software (BD Immunocytometry
Systems).
Genomic rearrangement of the k locus
B220
+ CD25
+ IgM
2 pre-BII cells were isolated from five age-
matched animals of each genotype by cell sorting. Genomic DNA
was isolated and equal amount of DNA was used in serial dilutions
to detect Vk-Jk rearrangements. For this, a universal Vk primer
[31] was used in combination with a specific Jk2 or Jk5. The Vk-
Jk DNA was amplified in a multiplex PCR for 35 cycles at 60uC
OBF-1 and l5 Silencing
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with Jk1 and Jk2,3 primers.
Vk universal F: GGCTGCAGSTTCAGTGGCAGTGGRTC
WGGRAC;
Jk2 R: TTTCCAGCTTGGTCCCCCCTCCGAA;
Jk5 R: TGCCACGTCAACTGATAATGAGCCCTCTC;
Vk1,2 F: AGAAGCTTGTGACTCAGGAATCTGCA;
Jk1 R: CAGGATCCTAGGACAGTCAGTTTGGT;
Jk2,3 R: CAGGATCCTAGGACAGTGACCTTG;
Affymetrix GeneChip analysis
Pre-BII cells (B220
+ CD25
+) were isolated from pooled bone
marrow of eight age-matched mice from each genotype. From
each genotype cells from two independent pools were purified.
Subsequently, total RNA was extracted as above and further
purified with the RNAeasy mini columns (Qiagen). Starting with
4 mg of total RNA, biotinylated cRNA probes were generated
using the SuperScript Choice cDNA sythesis kit from Stratagene
and the Affymetrix IVT kit. The labeled cRNA probes were
hybridized with the MOE430a Affymetrix GeneChips
TM and
signals were detected according to manufacturer’s instructions.
The GeneChips data analysis was performed using the Affymetrix
Microarray suite 5 and the GeneSpring 5 (Agilent Technologies,
Palo Alto, CA) analysis package. Only target intensities between
100 and 1000 in at least one genotype were used in the analysis.
The microarray data has been deposited in Gene Expression
Omnibus (GEO) system. The accession number is: GSE12356.
Chromatin immunoprecipitation assay
Crosslinking with formaldehyde and chromatin isolation from
A20J B cell line was performed as described [32]. Chromatin was
sonicated to an average fragment size from 200 to 600 bp followed
by 1:4-dilution before immunoprecipitation with 5 mg of anti-
OBF-1 (Santa Cruz) antibody. As a negative control, the
chromatin was immunoprecipitated with goat IgG isotype control
(Sigma). After crosslinking reversal, the immunoprecipitated DNA
was analyzed by real time PCR using the relative standard curve
method for normalization. The following primers were used in the
qPCR reactions:
ChIP PBS1 F: GGATAGACTTTGCATGTTTTTGAT;
ChIP PBS1 R: GGGGGATATTACCTGCTCTTT;
ChIP PBS2 F: CCTGGACTTGCCCATTTTTA;
ChIP PBS2 R: ATGATGGAATGCAGGTGACA;
ChIP PBS3 F: CTTTCTGCCACCACCTC TC;
ChIP PBS3 R: CTCCATGACCCTCAAATACCA;
ChIP Interg F: CAGCATTCCAGGAGGTTAGC;
ChIP Interg R: GTGCCTCATGTGCAGTCAGT;
3D DNA FISH
3D DNA FISH was carried out as described previously [33]. A
probe specific for c-satellite DNA labeled with dUTP-Cy5 and a
BAC clone (RP24–166A3, BAC PAC Resources) for VpreB1/l5,
labeled with dUTP-Cy3 were used [34]. Cells were analyzed by
confocal microscopy on a Leica SP2 AOBS (Acousta Optical
Beam Splitter). Optical sections were collected with sections
separated by a distance of 0.3 mm. Only cells with two l5 signals
(non-replicating) were evaluated.
Retroviral vectors and infections
The expression vector pBabe/puro/Bcl2 was provided by Dr. S.
Nutt (The Walter and Eliza Hall Institute, Australia). The
following primers were used for amplification:
VpreB1 XhoI F: AATTATCTCGAGGTCAGGGCCCAG
GAGCAG
VpreB1 EcoRI R: AATCATGAATTCAGACTAGCCGAG
CAAAGCAAACT
IRES BglII F: CTTGAGATCTGGGATCCGCC
IRES XhoI R: AATATCCTCGAGATTATCATCGTG
l5 clone 2 F: CCTGGGGTTTGGCTACAC
l5 clone 2 R: GAGGCTTCAGGGAGGATT
The VpreB1 cDNA was amplified by PCR and inserted between
the XhoI and EcoRI sites of the retroviral vector pMSCV/pgk/
EGFP. Subsequently, a 597 bp fragment containing an internal
ribosomal entry site was amplified by PCR from the retroviral
vector pMSCV/IRES/hCD2t and inserted into the BglII and
XhoI sites of pMSCV/VpreB1/pgk/EGFP. Finally, the l5 cDNA
was amplified by PCR and inserted upstream of the IRES
sequence into the HincII site of pMSCV/IRES/VpreB1/pgk/
EGFP, leading to pMSCV/l5/IRES/VpreB1/pgk/EGFP.
Phoenix-Eco packaging cells were transfected with pBabe/
puro/Bcl2, pMSCV/pgk/EGFP, or pMSCV/l5/IRES/VpreB1/
pgk/EGFP retroviral vectors by using calcium phosphate (Pro-
mega, Madison, USA) according to the manufacturer’s protocol.
Retroviral supernatants from of Phoenix-Eco packaging cells
cultured at 37uC were collected after 48 h. Next, the target cells
were centrifuged for 90 min at 1800 rpm at room temperature in
a retroviral supernatant. Cells were incubated for 90 min at 37uC
and submitted to another round of spin infection with fresh
retroviral supernatant.
In vitro maturation of pro/pre-B cells
59 Flourouracil treated bone marrow cells from C57BL/6 mice
were transduced and cultured as previously published [35]. In
short: 59 FU treated cells were transduced with pBabe/puro/Bcl2
and selected for Bcl2 expression by puromycin. Subsequently the
cells were cultured on OP9 stromal cells with IL-7 and Flt3 to
differentiate into pro/pre-B cells. These pro/pre-B cells were
transduced with either pMSCV/l5/IRES/VpreB1/pgk/EGFP or
the empty EGFP retroviral expression constructs. The transduced
cells were cultured without IL-7 on OP9 stromal cells for 5 or 7
days to induce further B cell maturation. The maturation state of
the transduced GFP
+ cells was determined by detection of surface
k light chain expression by flow cytometery.
Results
Transition from small pre-BII cells to immature B cells is
impaired in Aiolos/OBF-1 double mutant mice
The loss of either Aiolos or OBF-1 results in a reduction of
immature splenic B cells and impaired formation of MZ B cells
[10,15,22]. We have shown previously that the number of mature
resting B cells is only marginally altered in the single-mutant mice,
but is reduced several-fold in Aiolos
2/2/OBF-1
2/2 mice [21]. To
better understand the molecular basis of this phenomenon, we
have examined here early B cell development in mice of the
different genotypes. In agreement with our previous studies [21],
we found that immature B cells (B220
+ IgM
+ IgD
2) are severely
reduced in Aiolos/OBF-1 double - but not single-deficient or wild
type mice (Figure 1A). As previously reported [27], Aiolos single-
deficient mice showed an increase in the proportion of pre-BII
(B220
+ CD25
+ IgM
2) cells. Moreover, the double-deficient mice
exhibited a further small increase in the proportion of pre-BII
cells, although OBF-1 single-deficient mice showed no change in
this cell population (Figure 1B). To distinguish between the
dividing and non-dividing, but light chain rearranging cells, pre-
BII cells can be fractionated on the basis of their size (FSC).
OBF-1 and l5 Silencing
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2/2/OBF-1
2/2 mice. Flow cytometry analysis of bone
marrow cells from 6–10 weeks old control wild type, single- and double-deficient mice. (A) Analysis of B220
+ IgM
+ IgD
2 immature B cells in the bone
marrow. Cells were stained with anti-B220-APC, anti-IgM-FITC, anti-IgD-Biotin followed by Streptavidin-PE. Only IgD
2 cells are displayed and the
percentages indicated are relative to the IgD
2 cells. The percentage of IgD
2 cells from total cells are as follows: WT, 89%; Aiolos
2/2, 88%; OBF-1
2/2,
92%; Aio
2/2/OBF-1
2/2, 95%. (B) In the left part detection of B220
+ CD25
+ pre-BII B cells. In the right part, pre-BII (B220
+CD25
+) cells were gated and
their FSC analyzed. Percentages indicate the proportion of small or large cells. Data are presented from one representative experiment, out of three.
(C) Pre-BII cells (B220
+ CD25
+ IgM
2) were FACS sorted from wild type and Aiolos/OBF-1 double-deficient mice by flow cytometry. Serial dilutions of
the genomic DNA from the sorted cells were analyzed by PCR using primers detecting the indicated k and l light chain rearrangements. The relative
amount of DNA used in the reaction was adjusted according to a real time PCR for the 18S gene (not shown).
doi:10.1371/journal.pone.0003568.g001
OBF-1 and l5 Silencing
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population represented small non-dividing cells (Figure 1B), which
was also confirmed by DNA content analysis from sorted pre-BII
cell populations (data not shown).
Small pre-BII cells were used to determine the DNA
rearrangement status of the Ig k, l1, and l2 light chain genes.
We observed no difference in the rearrangement of Vks to Jk1,
Jk2 or Jk4 between wild type and double-mutant pre-BII cells
(Figure 1C). However, Aiolos
2/2/OBF-1
2/2 pre-BII cells showed
a five-fold reduction in Jk5 rearrangement compared to pre-BII
cells from control wild type littermates. Furthermore, the
rearrangement of the l1 and l2 genes was also reduced at least
fivefold in the double-mutant pre-BII cells. The reduction in Vk-
Jk5 and l light chain gene rearrangements in Aiolos/OBF-1
deficient mice suggests that the recombination process is
terminated prematurely during the small pre-BII cell stage. In
spite of this, k light chain rearrangement occurs in double-mutant
mice and intracellular expression of k light chains was detected in
the pre-BII cell population of these mice (data not shown). The
increase in small pre-BII cells concomitant with the reduction in
immature cells indicate that in the combined absence of Aiolos
and OBF-1 B cell development is impaired at the transition from
the small pre-BII to immature B cell stage.
Expression of Aiolos and OBF-1 during early B cell
development and influence of these factors on the gene
expression profiles of pre-BII cells
We next investigated by quantitative RT-PCR the expression
pattern of OBF-1 and Aiolos during B cell development. Both
genes showed a similar pattern of expression: low in pre-BI,
intermediate in pre-BII, high in immature B and intermediate in
mature B cells (Figure 2), thus supporting a role for these factors in
early B cell development. In order to determine the role of OBF-1
and Aiolos in pre-BII cells, the mRNA expression profile in pre-
BII cells from wild type, Aiolos or OBF-1 single-mutant and
double-mutant mice were measured, using the MOE430A
Affymetrix GeneChip (Figure 3A). Previous mRNA expression
analysis of OBF-1 deficient B cells have indicated a role for this
factor in regulating several genes, including Lck, Kcnn4, cdc37, Myla,
Ms4a11 or S100a10 [36,37], some of which were confirmed by our
present analysis (see Figure 3B). In comparing the transcriptomes
in cells of the four genotypes we found that the majority of genes
with a reduced mRNA expression in the double-mutant pre-BII
showed a similarly diminished expression in OBF-1
2/2 pre-BII
cells. Most of the genes that were upregulated in the double-
mutant pre-BII, were also partially upregulated in pre-BII cells
from either single-mutant mice. We found that the expression of
some genes, like RAMP1 (calcitonin receptor-activity modifying
protein 1), Gpr49 (a G-protein-coupled receptor), or Gsn (Gelsolin,
an actin binding and severing protein) was found to be
synergistically upregulated in the pre-BII cells from double-
deficient mice (Figure 3C). The mRNA expression of the major
players in immunoglobulin gene rearrangement (RAG1-2, dntt,
Ku70, polm) was not altered by the absence of Aiolos, OBF-1 or
both factors (data not shown). Strikingly, loss of Aiolos and OBF-1
altered the expression of the genes encoding the SLC, l5, VpreB1
and VpreB2 (Figure 3D). The role of Ikaros and Aiolos in regulating
expression of l5 was recently demonstrated [38,39]. This
regulatory role was confirmed by our observations of a 10-fold
increase of l5 mRNA expression levels in Aiolos deficient pre-BII
cells. Furthermore, the mRNA expression levels of VpreB1 and
VpreB2 were increased up to 7-fold in Aiolos deficient cells, thus
demonstrating a regulatory role of Aiolos for all members of the
surrogate light chain. Although l5 and VpreB1,2 mRNA levels
were only moderately elevated (2-fold) in OBF-1 deficient pre-BII
cells, expression of these genes was increased up to 25-fold in pre-
BII cells of the double-mutant mice (Figure 3D) indicating that l5,
VpreB1 and VpreB2 depend on both Aiolos and OBF-1 for their
correct expression.
Pre-BII cells lacking Aiolos and OBF-1 fail to
downregulate the components of the surrogate light
chain
The combined expression data from pooled large and small pre-
BII cells demonstrated strikingly elevated levels of VpreB1, 2 and l5
mRNA in Aiolos single- and Aiolos/OBF-1 double-mutant mice.
To determine whether this was the result of a net increase in
transcription or a failure to properly silence these loci during
development, l5 mRNA expression was determined by quantita-
tive RT-PCR in pre-BI cells, as well as in large or small pre-BII
cells (Figure 4A). In wild type animals the l5 gene was highly
expressed at the pre-BI cell stage and subsequently downregulated
more than ten-fold in large and small pre-BII cells, in agreement
with previous results [6,40]. Aiolos single-mutant mice showed
normal l5 mRNA levels in pre-BI cells, indicating that at this stage
Aiolos does not influence expression of the l5 gene. In contrast, in
large or small pre-BII cells from Aiolos
2/2 mice, l5 mRNA levels
were reduced only two-fold compared to the pre-BI stage. The
absence of OBF-1 led to a striking two-fold increase in l5
expression in pre-BI cells, but the downregulation in large and
small pre-BII cells was almost normal. Remarkably, the absence of
both Aiolos and OBF-1 resulted in elevated l5 mRNA levels in
pre-BI cells, which were sustained in both large and small pre-BII
cells (Figure 4A). In order to determine whether Aiolos
2/2/
OBF-1
2/2 mice are able to silence the expression of the l5 gene at
all, the expression of l5 mRNA was determined in splenic mature
resting B cells. As shown in Figure 4B, l5 mRNA was not detected
in splenic B cells, irrespective of genotype (See also Supplemental
Figure S1A). Thus, an additional silencing mechanism exists,
which is independent of Aiolos and OBF-1. In contrast to this, the
Gelsolin gene, which also showed increased expression levels in the
bone marrow of mutant mice, maintained elevated levels in splenic
B cells (Supplemental Figure S1A–B). This indicates that in
Aiolos
2/2/OBF-1
2/2 mice, the few B cells that migrate to the
spleen and develop into mature B cells, successfully silence the l5
locus, but are still deregulated in the mRNA expression of other
Aiolos/OBF-1 dependent genes.
In wild type pre-BII cells the pre-BCR has a high turnover and
most is retained in the endoplasmatic reticulum, resulting in low
expression at the cell surface [41,42]. However, mice with
impaired pre-BCR signaling, such as SLP65 or Irf4/Irf8 mutant
mice, show increased surface expression levels of the pre-BCR due
to impaired receptor internalization [43]. In order to test for a
change in surface pre-BCR or intracellular l5 expression, bone
marrow cells from wild type and mutant mice were stained with
specific antibodies against the pre-BCR and the l5 chain. By flow
cytometry analysis the single-and double-mutant mice showed no
significant increase in pre-BCR expression at the surface of bone
marrow B-lineage cells (Figure 4C). In contrast, the proportion of
B-lineage cells expressing intracellular l5 was two-or four-fold
increased in Aiolos and double-mutant mice, respectively, whereas
l5 protein levels determined by mean fluorescence levels in flow
cytometry were only marginally elevated (Figure 4C). Thus, the
increase in small, but not large, pre-BII cells in Aiolos and double
deficient mice indicates that the observed increase in l5 mRNA
and protein levels is not due to an accumulation of early B cells
that normally express l5 at higher levels, but rather is caused by
inappropriately high expression of the l5 locus in small pre-BII
OBF-1 and l5 Silencing
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higher in pre-BII B cells from Aiolos and double-mutant mice, the
mechanism of pre-BCR internalization is not impaired in the pre-
BII cells from these mice.
Direct regulation of l5 by Aiolos and OBF-1
In mice the l5 and VpreB genes are located on chromosome 16;
VpreB1 and l5 are separated by 4 kb and VpreB2 is located 1 Mb
downstream of the VpreB1-l5 locus. This region also contains a
gene encoding the ubiquitously expressed TopoisomeraseIIIb (Top3b)
which is located only 1.5 kb upstream from VpreB1 (Figure 5A).
Expression of the l5 and VpreB genes is initiated by and dependent
on the basic helix–loop–helix proteins E12 and E47 and on the
zinc finger/helix-loop-helix early B-cell factor (EBF) [44].
Although there are indications for a direct interaction of Aiolos/
Ikaros with the l5 promoter/enhancer region [38,45], no direct
interaction of OBF-1 with the l5 locus has been documented so
far. Bioinformatics analysis using PROMO [46] revealed three
putative octamer binding sites (Octamer 1: CTTTGCAT (2768
to 2775), Octamer 2: GTTTGCAT (22028 to 22035) and
Octamer 3: ATGCAAAT (23557 to 23550; consensus –
ATTTGCAT-) in the l5 59 regulatory region [47] (Figure 5A).
To determine whether OBF-1 is bound to these sites in vivo, the
B lymphoma line A20J was used for chromatin immunoprecip-
itation (ChIP) assays. Binding of OBF-1 was detected by ChIP
using an anti-OBF-1 antibody and formaldehyde-crosslinked
chromatin from A20J cells. Detection of the immunoprecipitated
DNA was done with a quantitative PCR assay. As shown in
Figure 5B, the two proximal octamer sites (sites 1 and 2) were both
enriched 5 to 6 fold in comparison to a ChIP done with control
IgG. In the same assay, the distal octamer site was even enriched
about 18 fold. Thus, all three identified octamer sites in the l5
regulatory region bind OBF-1 in B cells. These findings
demonstrate that OBF-1 can bind to the regulatory region of
the l5 locus in B cells and therefore may directly regulate l5
transcription.
The developmental repositioning of the l5 locus is
dependent on Aiolos and OBF-1
Recent studies by Parker et al. [34] have shown that the VpreB/
l5 genes are silenced in an asynchronous manner. Using RNA
and DNA FISH analysis, it was demonstrated that the VpreB/l5
genes are bi-allelically transcribed in pre-BI (CD19
+ c-kit
+), mono-
allelically in large pre-BII (B220
+ CD25
+ IgM
2) and are
subsequently completely repressed in small pre-BII cells (B220
+
CD25
+ IgM
2). This correlates with a sequential recruitment of the
VpreB/l5 alleles to centromeric DNA and translocation to the
nuclear periphery during early B cell development. Several earlier
studies have shown that recruitement of genes to heterochromatin
and repositioning to the nuclear periphery is a prerequisite for
their transcriptional silencing [48–50].
In order to determine the impact of Aiolos and OBF-1 on this
process, 3D DNA FISH was carried out on sorted pre-BI, small
pre-BII as well as splenic mature resting B cells from wild type and
mutant mice. A c-satellite probe was used to detect centromeric
clusters in conjunction with a VpreB/l5 locus probe (Figure 6A). In
wild-type pre-BI cells, the majority (65%) of cells has only one
VpreB1/l5 allele colocalizing with centromeric DNA and only a
small proportion (13%) of the cells show both alleles positioned at
the centromeric heterochromatin (Figure 6B). In the course of B
cell development, a shift can be observed, as the VpreB1/l5 alleles
become progressively recruited to the centromeric DNA at the
small pre-BII cell stage: at this stage a much greater proportion
(48%) of the cells have both alleles associated with centromeric
DNA and a minority of the cells (38%) have only one allele
centromeric. Finally, in the majority of mature splenic B cells the
VpreB1/l5 alleles are no longer centromerically-associated. In
addition, the recruitment to centromeric DNA is accompanied by
translocation of the alleles to the nuclear periphery: while ca. 60%
of VpreB/l5 alleles are peripheral in wild type pre-BI cells, in small
pre-BII or mature splenic B cells about 90% of the alleles are at the
nuclear periphery (Figure 6C).
In contrast to the wild-type, Aiolos deficient cells show a delayed
recruitment of alleles to the centromeric DNA at the small pre-BII
stage: a much smaller proportion of these cells have both VpreB1/
l5 alleles centromerically associated (12%, compared to 48% for
the wild type). Conversely, a much larger proportion of the cells
(47%) have the VpreB1/l5 alleles not associated with centromeric
DNA (Fig. 6B). Furthermore, the proportion of Aiolos
2/2 VpreB1/
l5 alleles relocalizing at the periphery does not increase in small
pre-BII cells and remains at ca. 70% (Fig. 6C). Yet, despite this
delayed recruitment at the small pre-BII stage, the majority (85%)
of the VpreB1/l5 alleles have repositioned to the nuclear periphery
in mature splenic Aiolos
2/2 B cells, as in wild type cells. Therefore,
delayed recruitment is observed only in the small pre-BII
population.
Similarly to the loss of Aiolos, the lack of OBF-1 leads to a
delayed centromeric recruitment and repositioning to the
nuclear periphery of the VpreB1/l5 alleles, albeit less severe
(Figure 6B): compared to Aiolos
2/2, a greater proportion of the
Figure 2. Expression pattern of Aiolos and OBF-1 in the bone
marrow. The indicated B cell fractions were sorted by FACS and
expression of Aiolos and OBF-1 was determined by real time RT-PCR and
normalized to the expression of Ubiquitin C. Similar results were
obtained when using RPII for normalization. The histograms represent
the mean6SE based on the analysis of at least three independent
samples per stage.
doi:10.1371/journal.pone.0003568.g002
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2/2 pre-BII cells have both VpreB1/l5 alleles located at
the centromere (28%, vs. 12% for Aiolos
2/2 cells). Furthermore,
the proportion of cells having both alleles located away from the
centromeres is smaller than in the case of the Aiolos mutation
(24%, vs. 47% for Aiolos
2/2 cells). Likewise, the level of
peripheral localization is greater than that observed in
Aiolos
2/2 small pre-BII cells, but less than what is seen in wild
type cells.
Figure 3. Identification of genes regulated by Aiolos and OBF-1 in pre-BII cells. Gene expression profiles in B220
+CD25
+ pre-BII cells were
determined by MOE430a Affymetrix GeneChip; for each genotype two RNA samples were prepared from independent pools of mice and microarray
analysis was done in duplicate. (A) 48 genes showed a 3 fold expression changes in single- or double-mutant pre-BII cells compared to pre-BII cells
from wild type mice (p-value cutoff: 0.05). The genes are grouped according to their expression profile in pre-BII cells from all genotypes. Low mRNA
expression, blue; high mRNA expression, red. (B) Expression of genes that have been reported previously to be dependent on OBF-1 expression: Myla,
Ms4a1, S100a10. (C) Expression of genes that show a strong expression increase specifically in Aio
2/2/OBF-1
2/2 pre-B cells: Ramp1, Gpr49, Gelsolin
(Gsn). (D) Expression of the surrogate light chain genes: l5, VpreB1 and VpreB2. Figures show raw Affymetrix expression score after array
normalization.
doi:10.1371/journal.pone.0003568.g003
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mutant mice revealed that in the absence of both factors the
observed phenotype of delayed recruitment and relocalisation of
alleles is further enhanced: a much smaller proportion (only 5%) of
the small pre-BII cells have both VpreB1/l5 alleles associated with
centromeric repeats and a much larger proportion of cells have the
VpreB1/l5 alleles entirely non-centromeric (57%). Likewise,
peripheral localization is further reduced in small pre-BII cells
Figure 4. Silencing of l5 expression at the pre-BII cell stage is impaired in absence of Aiolos and OBF-1. (A) l5 expression in pre-BI and
pre-BII cells of the different genotypes. Pre-BI cells (B220
+ckit
+IgM
2), large or small pre-BII cells (B220
+CD25
+IgM
2, discriminated on the basis of their
FSC profile) were sorted from wild type, single- and double-deficient mice and l5 expression was analyzed by real time RT-PCR. The histograms
represent the mean6SE based on the analysis of at least three independent samples per genotype/stage. (B) Downregulation of l5 expression in
Aiolos
2/2/OBF-1
2/2 splenic mature B cells. Small pre-BII (B220
+CD25
+IgM
2) and splenic mature B (B220
+IgM
lowIgD
high) cells of wild type, single- and
double-deficient mice were sorted and the expression analysis was done by real time RT-PCR, as above. The histograms represent the mean6SE
based on the analysis of two to three independent samples per genotype/stage. (C) Aiolos/OBF-1 double-deficient pre-BII cells fail to downregulate
l5 expression, but have a normal pre-BCR expression at the cell surface. Bone marrow cells from wild type, single- and double-mutant mice were
stained for B220 together with surface pre-BCR (left panels) or intracellular surrogate light chain (l5, right panels). Representative stainings are
presented.
doi:10.1371/journal.pone.0003568.g004
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of VpreB1/l5 alleles to centromeric heterochromatin and their
repositioning to the nuclear periphery depends primarily on Aiolos
but that OBF-1 also contributes to the process.
High VpreB1 and l5 expression interferes with B cell
maturation in vitro
The expression of members of the surrogate light chain VpreB1,
2 and l5 is tightly controlled at the transition from pre-BI, large
and small pre-BII, to immature B cells, suggesting that this
downregulation is essential. In order to test whether high levels of
the surrogate light chain could interfere with the maturation of
early B cell stages, we set out to overexpress l5 and VpreB1 in
early B cells, using a l5-IRES-VpreB1-EGFP retroviral expression
vector (Figure 7A). First, expression of VpreB1 and l5 from the
l5-IRES-VpreB1-EGFP retroviral vector was demonstrated by
transducing the immature B cell lymphoma WEHI231 and
staining for surface expression of total pre-BCR or l5
(Figure 7B). Although the SL and endogenous kappa light chain
(kLC) can compete for intracellular mHC, no reduction of surface
kLC was detected in l5-IRES-VpreB1-EGFP transduced WEHI231
cells, indicating an excess of endogenous intracellular mHC
(Figure 7B). Next, IL-7 dependent pro/pre-B cell cultures were
transduced with a construct expressing l5-IRES-VpreB1-EGFP,o r
with a control construct expressing only EGFP (see experimental
scheme in Figure 7C). Removal of IL-7 promotes maturation of
the cultured pro/pre-B cells into immature B cells which express
surface IgM [51] and kLC on their cell surface. After 5 to 7 days
culture in the absence of IL-7, l5-IRES-VpreB1-EGFP transduced
cells produced only ,50% of surface kLC
+ cells compared to
control transduced cells expressing only EGFP (Table 1). Hence,
Figure 5. OBF-1 binds to the l5 promoter region in vivo. (A) Organization of the l5 locus and partial sequence of the l5 promoter region.
Three putative octamer sites were identified in silico. (B) OBF-1 binds to the l5 regulatory region. Binding of OBF-1 to three putative octamer sites
(2769 to 2776), (22029 to 22036) and (23557 to 23550) was tested by ChIP analysis. As negative controls, ChIP assays were performed with
control IgGs, and control amplifications were done with a fragment of an intergenic region from chromosome 8 lacking any octamer site.
Immunoprecipitated DNA was quantified by real time PCR. One representative experiment is presented.
doi:10.1371/journal.pone.0003568.g005
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maturation of pro/pre-B cells to more mature kLC
+ expressing B
cells in vitro.
Discussion
Aiolos/OBF-1 double-deficient mice show a developmental
arrest at the transition from small to immature B cells. This block,
Figure 6. Developmentally regulated nuclear repositioning of the l5 locus is impaired in B lymphocytes lacking Aiolos or OBF-1. (A)
Representative pictures of the DNA FISH analysis. Confocal sections of nuclei after DNA FISH are shown, combining the l5 probe (red staining) with a
probe detecting c-satellite DNA (blue staining). The pictures show association of zero, one or both l5 alleles with c-satellite DNA. (B) Localization of
the l5 locus determined by DNA FISH analysis of bone marrow pre-BI (B220
+ c-kit
+ IgM
2), small pre-BII (B220
+ CD25
+ IgM
2), and splenic resting
mature B cells (CD4
2 CD43
2 Ter
2 119
2). Percentages of nuclei with one (red bar), both (yellow bar) or neither (blue bar) l5 allele associated with c-
satellite DNA in the indicated populations of wild type, single-and double-deficient mice. (C) Percentages of alleles located at the nuclear periphery in
the indicated cell populations.
doi:10.1371/journal.pone.0003568.g006
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phenotypes previously observed in Btk, SLP65, plcc and Irf4/Irf8
mutant mice whose development is arrested at the large pre-BII
cell stage [39,52–55]. For example, pre-BII cells deficient in Irf4/
Irf8 fail to exit the cell cycle, and have elevated pre-BCR on their
surface [39], unlike Aiolos
2/2/OBF-1
2/2 preB cells. It is worth
noting that the Irf4 and 8 genes are equally expressed in the pre-
BII cells of all the mice examined here (data not shown). A block at
the small pre-BII cell subset has also been observed in k/l double-
mutant mice [56]. Although we observed a significant reduction of
Figure 7. Assessing the role of VpreB1 and l5 expression for pro B cells maturation in vitro. (A) In the upper part a schematic of the
retroviral construct used to transduce pro/pre-B cells is presented. The control construct is identical, but only contains EGFP. (B) WEHI231 lymphoma
B cells were transduced with either VpreB1-IRES-l5-EGFP or an EGFP retroviral expression construct. Expression of VpreB1 and l5 was determined by
staining for surface expression of the pre-BCR (SL156) and l5 (LM34). Possible displacement of kLC on transduced WEHI231 cells was determined by
staining for surface kLC. Representative stainings are presented. (C) Schematic of the transduction experiment with bone marrow cells.
Hematopoietic stem cells (HSC) were first transduced with a Bcl-2 expressing retrovirus to enhance their survival and were differentiated into pro/
preB cultures in the presence of Flt3 and IL-7. Subsequently, these cultures were transduced with the indicated retroviruses and differentiated in vitro
by withdrawing IL-7.
doi:10.1371/journal.pone.0003568.g007
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double deficient pre-BII cells, most primary k light chain
rearrangements and k expression are normal in these mice. Thus,
loss of light chain expression can not explain the defect in B cell
maturation seen in Aiolos/OBF double-mutant mice. Gene
expression analysis of the pre-BII cell stage of all four genotypes
identified genes regulated by Aiolos and/or OBF-1 and some of
the previously identified target genes [36] were confirmed. No
major transcriptional changes were observed for any of the
commonly known components of the BCR signaling pathways
(Btk, SLP65, Syk, Lyn, PKCb, data not shown). Thus, a function for
OBF-1 in regulating Btk transcription in pre-B cells [57] could not
be confirmed here (data not shown).
Two recent studies have described Aiolos together with Ikaros
as regulators of SLC repression [38,58]. Our analysis confirmed
these observations and also additionally demonstrated an involve-
ment of OBF-1 in the regulation of the genes encoding the SLC.
ChIP experiments revealed that OBF-1 binds to three sites within
the l5 promoter region and thereby can directly influence the
regulation of the VpreB/l5 locus. In fact, OBF-1 deficient pre-BI
cells show a striking increase in l5 gene expression, which however
does not preclude a nearly normal silencing in pre-BII cells. The
two-fold increase of l5 mRNA expression in OBF-1 deficient pre-
BI cells indicates that at this stage OBF-1 may act as a repressor of
l5 transcription. All three OBF-1 binding sites that we identified
are located in a region upstream of the l5 gene that has been
recently described as a locus control region. This region is highly
H3-H4 dimethylated, H3 acetylated and is a target of transcription
factor recruitement (PolII, transcription factor IID complex, E2A,
PU.1) in pro/pre B cells [47]. Although OBF-1 has mostly been
considered to be a coactivator of Oct1 or Oct2 dependent
transcription, some evidence suggests that it may also contribute to
transcriptional repression [59–61]. So far, it has not been
established whether OBF1 binds to the l5 promoter together
with Oct1 or Oct2, and whether the observed repression may need
additional corepressors. However, binding of OBF-1 together with
potential corepressors could interfere with the recruitment of
essential transcription factors, thus decreasing transcriptional
activity of VpreB1 and l5. Another possibility is that OBF-1 is
not acting as a repressor, but that in its absence another, stronger,
transcriptional activator can bind and lead to elevated l5
expression.
It has been proposed that Ikaros, and not Aiolos is the essential
regulator of the VpreB/l5 locus [45,62]. Both Ikaros and Aiolos
can bind to two adjacent Ik1 and Ik2 sites proximal to the l5
transcription start site. Mutation of the more distal Ik2 site resulted
in an increased expression of a l5 transgene in activated B cells.
Because the Ik1 site overlaps with an EBF binding site within the
l5 promoter and because the relative amounts of EBF and E2A
have an effect on l5 transcription, it was proposed that Ikaros
mediates silencing of l5 by competing with EBF [63]. Two very
recent studies [38,58] have demonstrated that Ikaros can
counteract the effect of EBF on l5 expression, thereby promoting
a balanced l5 expression at the pre-BI cell stage. Furthermore, it
was found that Aiolos is likely to be the critical factor for silencing
the VpreB/l5 locus during early B cell development. The results
presented here confirm and extend the observations of these
studies and additionally show that OBF-1 also contributes to the
full silencing of the l5 locus.
Recently Parker et al. [34] have shown that silencing of this
locus is accompanied by sequential repositioning of VpreB/l5
alleles to the nuclear periphery and to pericentromeric hetero-
chromatic clusters. Our DNA FISH analysis shows that silencing
of VpreB/l5 expression and repositioning of the locus within the
nucleus during early B cell development is dependent on Aiolos
and also on OBF-1. Surprisingly, Aiolos deficient pre-BI cells
already exhibit an altered localization of the VpreB/l5 locus within
the nucleus, although at this stage no change in l5 expression is
seen. In contrast, OBF-1 deficient pre-BI cells show a two-fold
elevated l5 expression, which also coincides with an altered sub-
nuclear localization of VpreB/l5 alleles, but less pronounced than
in Aiolos deficient cells. Our observations suggest that Aiolos and
OBF-1 Aiolos and OBF-1 contribute by independent and different
molecular mechanisms to silencing of the VpreB/l5 locus.
Previous studies have demonstrated that Ikaros binds to
heterochromatin through multiple high affinity binding sites
[49,64]. These studies also suggested that Ikaros could directly
recruit different gene loci to heterochromatic sites. An Aiolos/
Ikaros heterodimer that binds to the l5 promoter region could
target the l5 locus to such high affinity binding sites within the
pericentromeric heterochromatic clusters.
The elevated VpreB/l5 expression observed in OBF-1
2/2 pre-
BI cells is important, as in absence of OBF-1 and Aiolos not only is
the silencing impaired, but the elevated expression is sustained
through early B cell development. At later stages Aiolos and OBF-
1 appear dispensable, as in mature B cells from Aiolos
2/2 or
Aiolos
2/2/OBF-1
2/2 mice the centromeric repositioning of the
VpreB/l5 alleles is very similar to the repositioning seen in
immature B cells from wild type mice (JAS et al., data not shown).
Furthermore, in splenic B cells of Aiolos
2/2 or Aiolos
2/2/OBF-1
2/2
mice, transcription of the VpreB/l5 locus is completely switched
off, as in wild type mice. This indicates that at the transition
Table 1. Expression of VpreB1 and l5 in pro-B cells impairs their maturation.
CD19
+ GFP
+ k
2 CD19
+ GFP
+ k
+
Experiment 1 7 days w/o IL-7 Control vector 76.3% 23.7%
VpreB1 l5 vector 85.3% 14.7%
Experiment 2 5 days w/o IL-7 Control vector 83.3% 16.7%
VpreB1 l5 vector 93.1% 6.9%
Experiment 3 5 days w/o IL-7 Control vector 89.6% 10.4%
VpreB1 l5 vector 94.6% 5.4%
IL-7 dependent pro-B cells were transduced with Bcl2 and either a VpreB1-IRES-l5-EGFP or an empty EGFP retroviral expression construct. B cell maturation was induced
by culturing the transduced pro/pre-B cells without IL-7 for 5 or 7 days, as schematized in Figure 7. The maturation state of the B cells was determined by staining for
surface kLC by flow cytometry. The table shows the percentage of more mature kLC positive and less mature kLC negative cells within the VpreB1-IRES-l5-EGFP
transduced or mock-transduced EGFP positive B cells.
doi:10.1371/journal.pone.0003568.t001
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exists to silence expression of the locus. This Aiolos and OBF-1
independent silencing pathway could be mediated through binding
of Ikaros homodimers at the l5 promoter. The complete silencing of
the VpreB/l5 locus observed in splenic B cells of double-deficient
mice also indicates that silencing is a prerequisite for immature B
cells to exit from the bone marrow compartment. Other genes that
are also deregulated in the bone marrow of mutant mice, but that
presumably do not affect the pre-B to immature transition, for
example Gelsolin, are still deregulated and increased in their
expression in the splenic B cells from Aiolos/OBF-1 double deficient
mice. In agreement with this, Gelsolin deficient mice [65] show a
normal B cell development in the bone marrow and periphery (AK
et al., data not shown). An alternative explanation could also be that
splenic mature B cells lack positive factors that are important for l5
transcription. However, based on different experimental evidences,
we propose that sustained elevated expression of VpreB/l5 interferes
with the normal transition from pre-BII to immature B cells. The
data presented here show that high expression of VpreB1 and l5 in
IL-7 dependent pre-B cells interferes with their maturation into k
light chain expressing cells upon IL-7 removal. These findings are in
agreement with a recent study demonstrating that altering the level
of VpreB2 expression impairs early B cell development [66].
Furthermore, the analysis of transgenic mice having a deregulated
expression of the pre-TCR also supports, by analogy, the hypothesis
that strong continuous expression of the pre-BCR can block B cell
development [67,68]. Finally, two very recent studies also support
and confirm our results [69,70]: In particular the analysis of VpreB1/
l5 double transgenic mice by Van Loo et al. [69] revealed a
reduction of immature B cells expressing high kLC and a block in
early B cell development.
Although Aiolos
2/2 or Aiolos
2/2/OBF-1
2/2 mice are both
impaired in l5 transcriptional silencing, only the double-deficient
mice have a block in the transition from pre-BII cells to immature
B cells. VpreB1/l5 mRNA expression levels are up to 10-fold
increased in small pre-BII cells, however this expression level could
be below the threshold needed to elicit the phenotype at this stage.
The additional increase in expression due to the loss of OBF-1
may be necessary to reach this threshold. A dosage effect has been
observed in the case of the pre-TCR; a block in T cell
development was detected only in mice with a high copy number
and corresponding expression level of the pTa transgene [67]. In
addition, high expression of the SLC in the small pre-BII cell
subset could interfere with the positive and negative selection
which occurs at the transition from small pre-BII to immature B
cells. Failure of positive or negative selection activates receptor
editing and secondary light chain rearrangements in immature B
cells [71,72]. Similarly, Van Loo et al. observed an increase in
lLC rearrangements in VpreB1/l5 double transgenic B cell [69].
However, the reduction of Vk-Jk5 and l light chain rearrange-
ments in Aiolos/OBF-1 double-mutant pre-BII cells suggests that
the rearrangement is delayed, leading to a reduction in secondary
rearrangements to Vk-Jk5 and the l light chain.
In summary: through this study, we are able to confirm the
role of Aiolos as a regulator of VpreB/l5 silencing. Moreover, we
could demonstrate that the developmentally regulated nuclear
repositioning of the VpreB/l5 locus is largely dependent on
Aiolos. In addition, we could identify a novel role for OBF-1 in
the regulation of VpreB/l5 expression, as well as for the nuclear
repositioning of the locus. Our findings suggest that Aiolos and
OBF-1 are likely to have independent and different molecular
functions in the regulation of VpreB/l5 expression. The
combined loss of Aiolos and OBF-1 ultimately leads to a block
of early B cell development at the transition from pre-BII to
immature B cells.
Supporting Information
Figure S1 Sustained cytoplasmic Gelsolin mRNA expression in
double-deficient splenic mature B cells. (A) Gene expression
profiles in IgD
+ IgM
low B220
+ mature splenic B cells were
determined by MOE430a Affymetrix GeneChip; for each
genotype two RNA samples were prepared from independent
pools of mice and microarray analysis was done in duplicate.
Figures show raw Affymetrix expression score after array
normalization for VprB1, VpreB2, l5, Gelsolin and OBF-1.( B )
Cytoplasmic Gelsolin expression in small pre-BII and mature
splenic B c ells was measured by real time RT-PCR. The real
time RT-PCR assays were normalized to the RNA polymerase II.
Found at: doi:10.1371/journal.pone.0003568.s001 (0.54 MB TIF)
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